|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online December 15, 2003
doi: 10.1242/10.1242/jcs.00924
Commentary |
1 Department of Pathology and Laboratory Medicine, Emory University School of Medicine, 615 Michael Street, Atlanta, GA 30322, USA
2 Departments of Neuroscience, Pharmacology and Molecular Science, and Psychiatry, Johns Hopkins University School of Medicine, 725 N. Wolfe Street, Baltimore, MD 21205, USA
* Author for correspondence (e-mail: kye{at}emory.edu)
Phosphoinositide (PI) 3-kinase enhancer (PIKE) is a brain-specific GTPase that binds to PI 3-kinase and stimulates its lipid kinase activity. It exists in two forms: the first to be identified, PIKE-S, is shorter and exclusively nuclear; by contrast, the longer form, PIKE-L, resides in multiple intracellular compartments. Nerve growth factor treatment leads to PIKE-S activation by triggering the nuclear translocation of phospholipase C (PLC)-
1, which acts as a physiological guanine nucleotide exchange factor (GEF) for PIKE-S through its Src-homlogy 3 (SH3) domain. Cytoplasmic PI 3-kinase and its lipid product phosphatidylinositol (3,4,5)-trisphosphate [PtdIns(3,4,5)P3] regulate the membrane translocation and activation of many signaling molecules by binding to their pleckstrin homology (PH) domains. However, little is known about the physiological roles of their nuclear counterparts. The nuclear PLC-1/PIKE-S/PI 3-kinase signaling pathway seems to be an extension of the crosstalk between cytoplasmic PLC-1 and PI 3-kinase. PIKE-L contains a C-terminal extension consisting of an ADP ribosylation-GTPase-activating protein (ArfGAP) domain and two ankyrin repeats in addition to the N-terminal GTPase domain. PIKE-L could have additional, extranuclear functions, including regulation of postsynaptic signaling by metabotropic glutamate receptors.
Key words: PIKE, GTPase, PI 3-kinase, 4.1N, PLC-1, GEF, ArfGAP
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Miyamoto, M. Rubio, and M. A. Sussman Nuclear and mitochondrial signalling Akts in cardiomyocytes Cardiovasc Res, May 1, 2009; 82(2): 272 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Kahn, E. Bruford, H. Inoue, J. M. Logsdon Jr., Z. Nie, R. T. Premont, P. A. Randazzo, M. Satake, A. B. Theibert, M. L. Zapp, et al. Consensus nomenclature for the human ArfGAP domain-containing proteins J. Cell Biol., September 22, 2008; 182(6): 1039 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Allen, L. M. DiPilato, B. Ananthanarayanan, R. H. Newman, Q. Ni, and J. Zhang Dynamic Visualization of Signaling Activities in Living Cells Sci. Signal., September 16, 2008; 1(37): pt6 - pt6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Liu, B. Tian, M. Gearing, S. Hunter, K. Ye, and Z. Mao Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion PNAS, May 27, 2008; 105(21): 7570 - 7575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gil, A. Andres-Pons, E. Fernandez, M. Valiente, J. Torres, J. Cervera, and R. Pulido Nuclear Localization of PTEN by a Ran-dependent Mechanism Enhances Apoptosis: Involvement of an N-Terminal Nuclear Localization Domain and Multiple Nuclear Exclusion Motifs Mol. Biol. Cell, September 1, 2006; 17(9): 4002 - 4013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Meyer, P. J. Kell, M. H. Creer, and J. McHowat Calcium-independent phospholipase A2 is regulated by a novel protein kinase C in human coronary artery endothelial cells Am J Physiol Cell Physiol, February 1, 2005; 288(2): C475 - C482. [Abstract] [Full Text] [PDF]
|
|
